Shares of Titan Medical are set to resume quotation at 9:45 am ET and resume trading at 9:50 am ET, according to Nasdaq. The stock was halted, news pending, before the company provided an update to the market on its previously announced review and evaluation of strategic alternatives and disclosed that none of "over 40 potential counterparties" expressed an interest in acquiring the company’s business.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on TMDI:
- Titan Medical Provides Corporate Update
- Titan Medical Shares Latest Technology Innovation and Announces Meeting Participation During J.P. Morgan Healthcare Conference Week
- Titan Medical receives noncompliance notification from Nasdaq
- Titan Medical Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing
- Titan Medical announces USPTO granted patent covering user experience